Abstract
Objectives
-
1.
Discuss the definition and incidence of underactive bladder (UAB).
-
2.
Describe assessment techniques in UAB.
-
3.
Discuss appropriate interventions for the treatment of UAB.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abrams P, Cardozo L, Fall M, Griffiths D et al. Standardisation Sub-committee of the International Continence Society (2002) The standardization of terminology of lower urinary tract function: report from the Standardisation Sub- committee of the International Continence Society. Neurol Urodyn 21(2):167–178
AHFS Drug Information (2009) BOTOX®. Retrieved 2 Sep 2009. From http://ashp.org/ahfs/index.cfm
American Urological Association. White paper on catheter-associated urinary tract infections: definitions and significance in the urologic patient 2014. Downloaded from https://www.auanet.org/common/pdf/education/clinical-guidance/Catheter-Associated-Urinary-Tract-Infections-WhitePaper.pdf. On 29 June 2015
Barendrecht MM, Oelke M, Laguna MP, Micheal MC (2007) Is the use of parasympathomimetics for treating an underactive bladder evidence based? BJU Int 99:749–752
Chancellor M (2009) Ten years single surgeon experience with botulinum toxin in the urinary tract: clinical observations and research discovery. Int Urol Nephrol J 42(2):383–391
Chancellor M (2014) The overactive bladder progression to underactive bladder hypothesis. Int Urol Nephrol 46(Suppl 1):523–527
Chancellor M, Diokno AC (2014) CURE-UAB shedding light on the underactive bladder syndrome. Int Urol Neph 46(Suppl 1):S1
Diokno A (2015) Evaluation and diagnosis of underactive bladder in The Underactive Bladder. In: Chancellor M: Diokino A (eds) pp 13–24
Diokno AC, Brock BM, Brown MB, Herzog AR (1986) Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol 136:1022–1025
Griebling T (2015) Geriatric Urology and Underactive Bladder in The Underactive Bladder. In: Chancellor M; Diokno A (eds) Springer Switzerland pp 177–188
Jamison J, Maquire S, Mcann J (2013) Catheter policies for management of long term voiding problems in adults with neurogenic bladder disorders (Review). Cochrane Libr 11:1–59
Lapides J, Diokno A, Silber S, Lowe B (1972) Clean intermittent self-catheterization in the treatment of urinary tract disease. J Urol 107(3):458–4613
McClurg D, Ashe RG, Marshall K, Lowe-Strong AS (2006) Comparison of pelvic floor muscle training, electromyography biofeedback and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study. Neurourol Urodyn 25:337–348
McClurg D, Ashe RG, Lowe-Strong AS (2008) Neuromuscular electrical stimulation and the treatment of lower urinary tract dysfunction in multiple sclerosis-a double blind, placebo controlled, randomised clinical trial. Neurourol Urodyn 27:231–237
Miyazato M, Yoshimura N, Chancellor M (2013) The other bladder syndrome: underactive bladder. Rev Urol 15(1):11–22
Newman D, Wein A (2009) Managing and treating urinary incontinence, 2nd edn. Health Professions Press, Baltimore, pp 365–483
Newman D, Wilson M (2011) Review of intermittent catheterization and current best practices. Urol Nurs 31(1):12–28
Osman N et al (2014) Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology aetiology and diagnosis. Eur Urol 65(2):389–398
Pannek J (2011) Treatment of Urinary Tract infection in persons with spinal cord injury: guidelines, evidence, and clinical practice. A questionnaire based survey and review of the literature. Journal of Spinal Cord Medicine, 34(1):11–15
Patil NJ, Nagaratna R, Garner C, Raghurman NV (2012) Effect of integrated yoga on neurogenic bladder dysfunction in patients with multiple sclerosis–a prospective observational series. Compliment Ther Med 20:424–430
Prieto J, Murphy CL, Moore KN, Fader M (2014) Catheterisation for long term bladder management (Review). Cochran Libr 9:1–97
Stohrer M, Blok B, Castro-Diaz D, Chartier-Kastler E, Del Popolo G, Kramer G, Pannek J, Piotr R, Wyandaele J (2009) EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol 56:81–88
Tubaro A, Puccini F, De Nunzio C, Diggesu GA, Elneil S, Gobbi C, Khullar V (2012) The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systemic review. Curr Urol Rep 13:335–342
Valente S, Du Beau C, Chancellor D et al (2014) Epidemiology and demographics of the underactive bladder: a cross sectional survey. Int Urol Nephrol 46 (Suppl):S7–S10
Weld K, Dmochowski R (2000) Effect of bladder management on urological complications in spinal cord injured patients. J Urol 163:768–772
Yoshimura N, Chancellor MB (2011) Physiology and pharmacology of the bladder and urethra. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbells Urology, 10th edn. Elsevier, Philadelphia PA, USA
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Lajiness, M.J. (2016). Neurogenic Bladder/Underactive Bladder. In: Lajiness, M., Quallich, S. (eds) The Nurse Practitioner in Urology. Springer, Cham. https://doi.org/10.1007/978-3-319-28743-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-28743-0_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28741-6
Online ISBN: 978-3-319-28743-0
eBook Packages: MedicineMedicine (R0)